There are several reasons. First, everyone else is--Pfizer just bought Wyeth, for instance. Second, the two companies have complimentary portfolios of prescription medicines, many of which are about ready to come off patent, and they don't have a massive amount of new products in the pipeline. Drugs are very expensive to bring to market, and they're starting to run out of new diseases to develop drugs to treat. Merck benefits here because Schering-Plough has a lot more drugs that aren't about to go off-patent than Merck does, and Schering-Plough has animal health and consumer health divisions Merck needs. Schering-Plough benefits because Merck is exceptionally well-funded and they have a vaccine business S-P needs. All is not happiness and joy, though; the merger is going to shed about 15,000 workers.
Merck & Co. is buying Schering-Plough Corp. for $41.1 billion.
Merck & Co. is an american pharmaceutical company.
Merck & Co. announced its acquisition of Schering-Plough in March 2009, completing the deal in November of the same year. Following the announcement, Schering-Plough shares rose significantly, reflecting investor confidence in the merger and the premium offered by Merck. The deal was valued at approximately $41.1 billion, marking one of the largest pharmaceutical mergers at the time.
There are several reasons. First, everyone else is--Pfizer just bought Wyeth, for instance. Second, the two companies have complimentary portfolios of prescription medicines, many of which are about ready to come off patent, and they don't have a massive amount of new products in the pipeline. Drugs are very expensive to bring to market, and they're starting to run out of new diseases to develop drugs to treat. Merck benefits here because Schering-Plough has a lot more drugs that aren't about to go off-patent than Merck does, and Schering-Plough has animal health and consumer health divisions Merck needs. Schering-Plough benefits because Merck is exceptionally well-funded and they have a vaccine business S-P needs. All is not happiness and joy, though; the merger is going to shed about 15,000 workers.
Merck & Co. (formerly Schering-Plough)
No. Merck, the German pharmaceutical company invented MDMA in the early 1900s.
yes ... žMDMA was first synthesised by a German chemist in 1914 is was controlled by Merck Pharmaceutical Company
Merck Serono is the name of a pharmaceutical company based in Switzerland. In the United States and Canada, it is known as EMD Serono. It was formed in 2006 by a merger between Merk and the smaller Serono corporation.
The Merck Index, a comprehensive resource of chemical compounds and information, was first published in 1889 by the pharmaceutical company Merck. It has since undergone multiple editions and revisions to keep up with new discoveries and research in chemistry.
Top 20 Pharmaceutical Companies1 Pfizer : $44,1742 Sanofi-Aventis : $40,5623 GlaxoSmithKline : $37,8104 Novartis : $35,6475 AstraZeneca : $30,6776 Merck : $25,9017 Johnson & Johnson : $24,5678 Roche : $23,6249 Eli Lilly : $19,28510 Bristol-Myers Squibb : $17,71511 Wyeth : $17,39112 Schering-Plough : $16,53413 Abbott Laboratories : $16,01314 Takeda : $13,84115 Bayer Schering : $13,80316 Boehringer Ingelheim : $13,40517 Teva : 10,48218 Astellas : $9,64619 Daiichi-Sankyo : $7,90020 Eisai : $7,612
Lupin
Fosamax is made by Merck & Co., Inc., a pharmaceutical company headquartered in the United States. It is used to treat osteoporosis and other bone-related conditions.